5 Best Long-term Stocks To Buy For High Returns

In this piece, we will take a look at the five best long term stocks to buy for high returns. If you want to learn more about long term investing, then head on over to 11 Best Long-term Stocks To Buy For High Returns.

5. First Solar, Inc. (NASDAQ:FSLR)

Number of Hedge Fund Investors in Q2 2023: 51

First Solar, Inc. (NASDAQ:FSLR) is another solar power company. It sells solar panels to industrial and other large scale users. The firm’s shares are rated Buy on average, and it scored a win in October 2023 when Barclays upgraded the shares to Overweight but lowered the price target to $224 from $230.

As of Q2 2023 end, 51 out of the 910 hedge funds part of Insider Monkey’s database had held First Solar, Inc. (NASDAQ:FSLR)’s shares. Out of these, the firm’s biggest investor is Robert Pohly’s Samlyn Capital since it owns 1.2 million shares that are worth $239 million.

4. The PNC Financial Services Group, Inc. (NYSE:PNC)

Number of Hedge Fund Investors in Q2 2023: 52

The PNC Financial Services Group, Inc. (NYSE:PNC) is an American regional bank headquartered in Pittsburgh, Pennsylvania. Despite the turmoil in the regional banking industry earlier this year, the firm has beaten analyst EPS for all its quarters in 2023. However, the third quarter earnings report saw The PNC Financial Services Group, Inc. (NYSE:PNC) warn about layoffs as its profit dropped annually during the quarter.

As of June 2023, 52 among the 910 hedge funds polled by Insider Monkey had bought the bank’s shares. The PNC Financial Services Group, Inc. (NYSE:PNC)’s largest shareholder out of these is Peter Rathjens, Bruce Clarke, and John Campbell Arrowstreet Capital due to a $186 million stake.

3. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Number of Hedge Fund Investors in Q2 2023: 53

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biotechnology firm that seeks to leverage gene therapies to treat serious diseases. It’s another stock that is rated Strong Buy on average, and the average analyst share price target of $180.61 sets a massive $62 share price upside over the current share price of $117.96.

After digging through 910 hedge funds for their second quarter of 2023 shareholdings, Insider Monkey found 53 Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investors. Kurt Von Emster’s VenBio Select Advisor is the biggest investor among these as it owns $529 million worth of shares.

2. Albemarle Corporation (NYSE:ALB)

Number of Hedge Fund Investors in Q2 2023: 57

Albemarle Corporation (NYSE:ALB) is an American chemicals company that is one of the biggest lithium companies in the world. The firm is currently trying to buy an Australian lithium company for a $4.24 billion price tag, but the deal is facing hurdles from shareholders.

By the end of this year’s second quarter, 57 out of the 910 hedge funds tracked by Insider Monkey had bought and owned the chemicals company’s shares. Out of these, Albemarle Corporation (NYSE:ALB)’s largest shareholder is Philippe Laffont’s Coatue Management as it owns 691,853 shares that are worth $154 million.

1. DexCom, Inc. (NASDAQ:DXCM)

Number of Hedge Fund Investors in Q2 2023: 58

DexCom, Inc. (NASDAQ:DXCM) is a medical devices company that sells glucose monitoring systems and provides related software support. Analysts have rated the shares Strong Buy on average and priced in an 86% share price upside through an average share price target of $141.94.

Insider Monkey dug through 910 hedge fund holdings and found 58 DexCom, Inc. (NASDAQ:DXCM) during Q2 2023. Israel Englander’s Millennium Management is the firm’s biggest hedge fund investor courtesy of its $244 million.

Disclosure: None. You can also take a look at 16 Best Growth Stocks To Buy According To Hedge Funds and 10 Special Situation Penny Stocks With Near Term Catalysts.

Follow Insider Monkey on Twitter